Medical Care
Global Anti-inflammatory Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jul 08, 25
- ID: 350157
- Pages: 131
- Figures: 134
- Views: 3
In 2024, the global market size of Anti-inflammatory Therapeutics was estimated to be worth US$ 124330 million and is forecast to reach approximately US$ 187100 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics.
The Anti-inflammatory Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-inflammatory Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Anti-inflammatory Therapeutics in global and regional level.
Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-inflammatory Therapeutics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics.
The Anti-inflammatory Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-inflammatory Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Anti-inflammatory Therapeutics in global and regional level.
Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-inflammatory Therapeutics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Anti-inflammatory Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-inflammatory Therapeutics Market Size Estimates and Forecasts
2.2 Anti-inflammatory Therapeutics Market Size by Region: 2024 Versus 2031
2.2.1 Global Anti-inflammatory Therapeutics Revenue by Region: 2020-2025
2.2.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Region (2026-2031)
2.2.3 Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Anti-inflammatory Therapeutics Revenue by Type (2020-2031)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Anti-inflammatory Therapeutics Revenue by Application (2020-2031)
3.2.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Anti-inflammatory Biologics of Anti-inflammatory Therapeutics Revenue Market Share by Application
3.3.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) of Anti-inflammatory Therapeutics Revenue Market Share by Application
3.3.3 Corticosteroids of Anti-inflammatory Therapeutics Revenue Market Share by Application
3.3.4 Others of Anti-inflammatory Therapeutics Revenue Market Share by Application
4 Global Anti-inflammatory Therapeutics by Company
4.1 Global Anti-inflammatory Therapeutics Revenue by Company (2020-2025)
4.2 Global Anti-inflammatory Therapeutics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Anti-inflammatory Therapeutics Companies around the World: Ranking by Revenue
4.3.2 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Anti-inflammatory Therapeutics Companies Headquarters & Product Type
4.4.1 Global Anti-inflammatory Therapeutics Companies Headquarters
4.4.2 Date of International Companies Enter into Anti-inflammatory Therapeutics Market
4.4.3 Global Anti-inflammatory Therapeutics Companies Product & Service
4.4.4 Anti-inflammatory Biologics Revenue Market Share of Anti-inflammatory Therapeutics by Company
4.4.5 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Revenue Market Share of Anti-inflammatory Therapeutics by Company
4.4.6 Corticosteroids Revenue Market Share of Anti-inflammatory Therapeutics by Company
4.4.7 Others Revenue Market Share of Anti-inflammatory Therapeutics by Company
4.5 Global Anti-inflammatory Therapeutics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AbbVie
5.1.1 AbbVie Corporation Information
5.1.2 AbbVie Description, Business Overview
5.1.3 AbbVie Anti-inflammatory Therapeutics Products Offered
5.1.4 AbbVie Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.1.5 AbbVie Anti-inflammatory Therapeutics Revenue by Product in 2024
5.1.6 AbbVie Anti-inflammatory Therapeutics Revenue by Application in 2024
5.1.7 AbbVie Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.1.8 AbbVie Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Corporation Information
5.2.2 Johnson & Johnson Description, Business Overview
5.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Products Offered
5.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.2.5 Johnson & Johnson Anti-inflammatory Therapeutics Revenue by Product in 2024
5.2.6 Johnson & Johnson Anti-inflammatory Therapeutics Revenue by Application in 2024
5.2.7 Johnson & Johnson Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.2.8 Johnson & Johnson Recent Developments
5.3 Amgen Inc
5.3.1 Amgen Inc Corporation Information
5.3.2 Amgen Inc Description, Business Overview
5.3.3 Amgen Inc Anti-inflammatory Therapeutics Products Offered
5.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.3.5 Amgen Inc Anti-inflammatory Therapeutics Revenue by Product in 2024
5.3.6 Amgen Inc Anti-inflammatory Therapeutics Revenue by Application in 2024
5.3.7 Amgen Inc Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.3.8 Amgen Inc Recent Developments
5.4 AstraZeneca PLC
5.4.1 AstraZeneca PLC Corporation Information
5.4.2 AstraZeneca PLC Description, Business Overview
5.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Products Offered
5.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.4.5 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue by Product in 2024
5.4.6 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue by Application in 2024
5.4.7 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.4.8 AstraZeneca PLC Recent Developments
5.5 Pfizer, Inc
5.5.1 Pfizer, Inc Corporation Information
5.5.2 Pfizer, Inc Description, Business Overview
5.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Products Offered
5.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.5.5 Pfizer, Inc Anti-inflammatory Therapeutics Revenue by Product in 2024
5.5.6 Pfizer, Inc Anti-inflammatory Therapeutics Revenue by Application in 2024
5.5.7 Pfizer, Inc Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.5.8 Pfizer, Inc Recent Developments
5.6 Novartis
5.6.1 Novartis Corporation Information
5.6.2 Novartis Description, Business Overview
5.6.3 Novartis Anti-inflammatory Therapeutics Products Offered
5.6.4 Novartis Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.6.5 Novartis Anti-inflammatory Therapeutics Revenue by Product in 2024
5.6.6 Novartis Anti-inflammatory Therapeutics Revenue by Application in 2024
5.6.7 Novartis Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.6.8 Novartis Recent Developments
5.7 Roche
5.7.1 Roche Corporation Information
5.7.2 Roche Description, Business Overview
5.7.3 Roche Anti-inflammatory Therapeutics Products Offered
5.7.4 Roche Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.7.5 Roche Anti-inflammatory Therapeutics Revenue by Product in 2024
5.7.6 Roche Anti-inflammatory Therapeutics Revenue by Application in 2024
5.7.7 Roche Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.7.8 Roche Recent Developments
5.8 Merck
5.8.1 Merck Corporation Information
5.8.2 Merck Description, Business Overview
5.8.3 Merck Anti-inflammatory Therapeutics Products Offered
5.8.4 Merck Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.8.5 Merck Anti-inflammatory Therapeutics Revenue by Product in 2024
5.8.6 Merck Anti-inflammatory Therapeutics Revenue by Application in 2024
5.8.7 Merck Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.8.8 Merck Recent Developments
5.9 Sanofi
5.9.1 Sanofi Corporation Information
5.9.2 Sanofi Description, Business Overview
5.9.3 Sanofi Anti-inflammatory Therapeutics Products Offered
5.9.4 Sanofi Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.9.5 Sanofi Anti-inflammatory Therapeutics Revenue by Product in 2024
5.9.6 Sanofi Anti-inflammatory Therapeutics Revenue by Application in 2024
5.9.7 Sanofi Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.9.8 Sanofi Recent Developments
5.10 GlaxoSmithKline
5.10.1 GlaxoSmithKline Corporation Information
5.10.2 GlaxoSmithKline Description, Business Overview
5.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Products Offered
5.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.10.5 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue by Product in 2024
5.10.6 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue by Application in 2024
5.10.7 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.10.8 GlaxoSmithKline Recent Developments
5.11 Sun Pharmaceutical Industries Ltd
5.11.1 Sun Pharmaceutical Industries Ltd Corporation Information
5.11.2 Sun Pharmaceutical Industries Ltd Description, Business Overview
5.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Products Offered
5.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.11.5 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue by Product in 2024
5.11.6 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue by Application in 2024
5.11.7 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.11.8 Sun Pharmaceutical Industries Ltd Recent Developments
5.12 TEVA
5.12.1 TEVA Corporation Information
5.12.2 TEVA Description, Business Overview
5.12.3 TEVA Anti-inflammatory Therapeutics Products Offered
5.12.4 TEVA Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.12.5 TEVA Anti-inflammatory Therapeutics Revenue by Product in 2024
5.12.6 TEVA Anti-inflammatory Therapeutics Revenue by Application in 2024
5.12.7 TEVA Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.12.8 TEVA Recent Developments
6 North America
6.1 North America Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
6.2 North America Anti-inflammatory Therapeutics Market Facts & Figures by Country (2020-2031)
6.3 North America Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
6.4 North America Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Anti-inflammatory Therapeutics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
7.4 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
8.2 Europe Anti-inflammatory Therapeutics Market Facts & Figures by Country (2020-2031)
8.3 Europe Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
8.4 Europe Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
9.2 Latin America Anti-inflammatory Therapeutics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
9.4 Latin America Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Anti-inflammatory Therapeutics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
10.4 Middle East and Africa Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Anti-inflammatory Therapeutics Supply Chain Analysis
11.2 Anti-inflammatory Therapeutics Key Raw Materials and Upstream Suppliers
11.3 Anti-inflammatory Therapeutics Clients Analysis
11.4 Anti-inflammatory Therapeutics Sales Channel and Sales Model Analysis
11.4.1 Anti-inflammatory Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Anti-inflammatory Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Anti-inflammatory Therapeutics Distributors
12 Anti-inflammatory Therapeutics Market Dynamics
12.1 Anti-inflammatory Therapeutics Industry Trends
12.2 Anti-inflammatory Therapeutics Market Drivers
12.3 Anti-inflammatory Therapeutics Market Challenges
12.4 Anti-inflammatory Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Anti-inflammatory Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-inflammatory Therapeutics Market Size Estimates and Forecasts
2.2 Anti-inflammatory Therapeutics Market Size by Region: 2024 Versus 2031
2.2.1 Global Anti-inflammatory Therapeutics Revenue by Region: 2020-2025
2.2.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Region (2026-2031)
2.2.3 Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Anti-inflammatory Therapeutics Revenue by Type (2020-2031)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Anti-inflammatory Therapeutics Revenue by Application (2020-2031)
3.2.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Anti-inflammatory Biologics of Anti-inflammatory Therapeutics Revenue Market Share by Application
3.3.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) of Anti-inflammatory Therapeutics Revenue Market Share by Application
3.3.3 Corticosteroids of Anti-inflammatory Therapeutics Revenue Market Share by Application
3.3.4 Others of Anti-inflammatory Therapeutics Revenue Market Share by Application
4 Global Anti-inflammatory Therapeutics by Company
4.1 Global Anti-inflammatory Therapeutics Revenue by Company (2020-2025)
4.2 Global Anti-inflammatory Therapeutics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Anti-inflammatory Therapeutics Companies around the World: Ranking by Revenue
4.3.2 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Anti-inflammatory Therapeutics Companies Headquarters & Product Type
4.4.1 Global Anti-inflammatory Therapeutics Companies Headquarters
4.4.2 Date of International Companies Enter into Anti-inflammatory Therapeutics Market
4.4.3 Global Anti-inflammatory Therapeutics Companies Product & Service
4.4.4 Anti-inflammatory Biologics Revenue Market Share of Anti-inflammatory Therapeutics by Company
4.4.5 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Revenue Market Share of Anti-inflammatory Therapeutics by Company
4.4.6 Corticosteroids Revenue Market Share of Anti-inflammatory Therapeutics by Company
4.4.7 Others Revenue Market Share of Anti-inflammatory Therapeutics by Company
4.5 Global Anti-inflammatory Therapeutics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 AbbVie
5.1.1 AbbVie Corporation Information
5.1.2 AbbVie Description, Business Overview
5.1.3 AbbVie Anti-inflammatory Therapeutics Products Offered
5.1.4 AbbVie Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.1.5 AbbVie Anti-inflammatory Therapeutics Revenue by Product in 2024
5.1.6 AbbVie Anti-inflammatory Therapeutics Revenue by Application in 2024
5.1.7 AbbVie Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.1.8 AbbVie Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Corporation Information
5.2.2 Johnson & Johnson Description, Business Overview
5.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Products Offered
5.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.2.5 Johnson & Johnson Anti-inflammatory Therapeutics Revenue by Product in 2024
5.2.6 Johnson & Johnson Anti-inflammatory Therapeutics Revenue by Application in 2024
5.2.7 Johnson & Johnson Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.2.8 Johnson & Johnson Recent Developments
5.3 Amgen Inc
5.3.1 Amgen Inc Corporation Information
5.3.2 Amgen Inc Description, Business Overview
5.3.3 Amgen Inc Anti-inflammatory Therapeutics Products Offered
5.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.3.5 Amgen Inc Anti-inflammatory Therapeutics Revenue by Product in 2024
5.3.6 Amgen Inc Anti-inflammatory Therapeutics Revenue by Application in 2024
5.3.7 Amgen Inc Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.3.8 Amgen Inc Recent Developments
5.4 AstraZeneca PLC
5.4.1 AstraZeneca PLC Corporation Information
5.4.2 AstraZeneca PLC Description, Business Overview
5.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Products Offered
5.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.4.5 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue by Product in 2024
5.4.6 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue by Application in 2024
5.4.7 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.4.8 AstraZeneca PLC Recent Developments
5.5 Pfizer, Inc
5.5.1 Pfizer, Inc Corporation Information
5.5.2 Pfizer, Inc Description, Business Overview
5.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Products Offered
5.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.5.5 Pfizer, Inc Anti-inflammatory Therapeutics Revenue by Product in 2024
5.5.6 Pfizer, Inc Anti-inflammatory Therapeutics Revenue by Application in 2024
5.5.7 Pfizer, Inc Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.5.8 Pfizer, Inc Recent Developments
5.6 Novartis
5.6.1 Novartis Corporation Information
5.6.2 Novartis Description, Business Overview
5.6.3 Novartis Anti-inflammatory Therapeutics Products Offered
5.6.4 Novartis Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.6.5 Novartis Anti-inflammatory Therapeutics Revenue by Product in 2024
5.6.6 Novartis Anti-inflammatory Therapeutics Revenue by Application in 2024
5.6.7 Novartis Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.6.8 Novartis Recent Developments
5.7 Roche
5.7.1 Roche Corporation Information
5.7.2 Roche Description, Business Overview
5.7.3 Roche Anti-inflammatory Therapeutics Products Offered
5.7.4 Roche Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.7.5 Roche Anti-inflammatory Therapeutics Revenue by Product in 2024
5.7.6 Roche Anti-inflammatory Therapeutics Revenue by Application in 2024
5.7.7 Roche Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.7.8 Roche Recent Developments
5.8 Merck
5.8.1 Merck Corporation Information
5.8.2 Merck Description, Business Overview
5.8.3 Merck Anti-inflammatory Therapeutics Products Offered
5.8.4 Merck Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.8.5 Merck Anti-inflammatory Therapeutics Revenue by Product in 2024
5.8.6 Merck Anti-inflammatory Therapeutics Revenue by Application in 2024
5.8.7 Merck Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.8.8 Merck Recent Developments
5.9 Sanofi
5.9.1 Sanofi Corporation Information
5.9.2 Sanofi Description, Business Overview
5.9.3 Sanofi Anti-inflammatory Therapeutics Products Offered
5.9.4 Sanofi Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.9.5 Sanofi Anti-inflammatory Therapeutics Revenue by Product in 2024
5.9.6 Sanofi Anti-inflammatory Therapeutics Revenue by Application in 2024
5.9.7 Sanofi Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.9.8 Sanofi Recent Developments
5.10 GlaxoSmithKline
5.10.1 GlaxoSmithKline Corporation Information
5.10.2 GlaxoSmithKline Description, Business Overview
5.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Products Offered
5.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.10.5 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue by Product in 2024
5.10.6 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue by Application in 2024
5.10.7 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.10.8 GlaxoSmithKline Recent Developments
5.11 Sun Pharmaceutical Industries Ltd
5.11.1 Sun Pharmaceutical Industries Ltd Corporation Information
5.11.2 Sun Pharmaceutical Industries Ltd Description, Business Overview
5.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Products Offered
5.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.11.5 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue by Product in 2024
5.11.6 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue by Application in 2024
5.11.7 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.11.8 Sun Pharmaceutical Industries Ltd Recent Developments
5.12 TEVA
5.12.1 TEVA Corporation Information
5.12.2 TEVA Description, Business Overview
5.12.3 TEVA Anti-inflammatory Therapeutics Products Offered
5.12.4 TEVA Anti-inflammatory Therapeutics Revenue and Gross Margin (2020-2025)
5.12.5 TEVA Anti-inflammatory Therapeutics Revenue by Product in 2024
5.12.6 TEVA Anti-inflammatory Therapeutics Revenue by Application in 2024
5.12.7 TEVA Anti-inflammatory Therapeutics Revenue by Geographic Area in 2024
5.12.8 TEVA Recent Developments
6 North America
6.1 North America Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
6.2 North America Anti-inflammatory Therapeutics Market Facts & Figures by Country (2020-2031)
6.3 North America Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
6.4 North America Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Anti-inflammatory Therapeutics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
7.4 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
8.2 Europe Anti-inflammatory Therapeutics Market Facts & Figures by Country (2020-2031)
8.3 Europe Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
8.4 Europe Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
9.2 Latin America Anti-inflammatory Therapeutics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
9.4 Latin America Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Anti-inflammatory Therapeutics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Anti-inflammatory Therapeutics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Anti-inflammatory Therapeutics Revenue by Type (2020-2025)
10.4 Middle East and Africa Anti-inflammatory Therapeutics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Anti-inflammatory Therapeutics Supply Chain Analysis
11.2 Anti-inflammatory Therapeutics Key Raw Materials and Upstream Suppliers
11.3 Anti-inflammatory Therapeutics Clients Analysis
11.4 Anti-inflammatory Therapeutics Sales Channel and Sales Model Analysis
11.4.1 Anti-inflammatory Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Anti-inflammatory Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Anti-inflammatory Therapeutics Distributors
12 Anti-inflammatory Therapeutics Market Dynamics
12.1 Anti-inflammatory Therapeutics Industry Trends
12.2 Anti-inflammatory Therapeutics Market Drivers
12.3 Anti-inflammatory Therapeutics Market Challenges
12.4 Anti-inflammatory Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Anti-inflammatory Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Anti-inflammatory Therapeutics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Anti-inflammatory Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Anti-inflammatory Therapeutics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Anti-inflammatory Therapeutics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Anti-inflammatory Therapeutics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Anti-inflammatory Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Anti-inflammatory Therapeutics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Anti-inflammatory Therapeutics Players by Revenue (US$ Million) in 2024
Table 13. Global Anti-inflammatory Therapeutics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2024)
Table 15. Global Anti-inflammatory Therapeutics Companies Headquarters
Table 16. Date of International Companies Enter into Anti-inflammatory Therapeutics Market
Table 17. Global Anti-inflammatory Therapeutics Companies Product & Service
Table 18. Global Anti-inflammatory Therapeutics Mergers & Acquisitions, Expansion Plans
Table 19. AbbVie Corporation Information
Table 20. AbbVie Description and Business Overview
Table 21. AbbVie Anti-inflammatory Therapeutics Product
Table 22. AbbVie Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. AbbVie Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 24. AbbVie Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 25. AbbVie Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 26. AbbVie Recent Developments
Table 27. Johnson & Johnson Corporation Information
Table 28. Johnson & Johnson Description and Business Overview
Table 29. Johnson & Johnson Anti-inflammatory Therapeutics Product
Table 30. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Johnson & Johnson Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 32. Johnson & Johnson Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 33. Johnson & Johnson Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 34. Johnson & Johnson Recent Developments
Table 35. Amgen Inc Corporation Information
Table 36. Amgen Inc Description and Business Overview
Table 37. Amgen Inc Anti-inflammatory Therapeutics Product
Table 38. Amgen Inc Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Amgen Inc Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 40. Amgen Inc Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 41. Amgen Inc Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 42. Amgen Inc Recent Developments
Table 43. AstraZeneca PLC Corporation Information
Table 44. AstraZeneca PLC Description and Business Overview
Table 45. AstraZeneca PLC Anti-inflammatory Therapeutics Product
Table 46. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. AstraZeneca PLC Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 48. AstraZeneca PLC Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 49. AstraZeneca PLC Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 50. AstraZeneca PLC Recent Developments
Table 51. Pfizer, Inc Corporation Information
Table 52. Pfizer, Inc Description and Business Overview
Table 53. Pfizer, Inc Anti-inflammatory Therapeutics Product
Table 54. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Pfizer, Inc Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 56. Pfizer, Inc Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 57. Pfizer, Inc Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 58. Pfizer, Inc Recent Developments
Table 59. Novartis Corporation Information
Table 60. Novartis Description and Business Overview
Table 61. Novartis Anti-inflammatory Therapeutics Product
Table 62. Novartis Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Novartis Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 64. Novartis Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 65. Novartis Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 66. Novartis Recent Developments
Table 67. Roche Corporation Information
Table 68. Roche Description and Business Overview
Table 69. Roche Anti-inflammatory Therapeutics Product
Table 70. Roche Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Roche Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 72. Roche Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 73. Roche Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 74. Roche Recent Developments
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Anti-inflammatory Therapeutics Product
Table 78. Merck Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Merck Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 80. Merck Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 81. Merck Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 82. Merck Recent Developments
Table 83. Sanofi Corporation Information
Table 84. Sanofi Description and Business Overview
Table 85. Sanofi Anti-inflammatory Therapeutics Product
Table 86. Sanofi Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Sanofi Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 88. Sanofi Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 89. Sanofi Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 90. Sanofi Recent Developments
Table 91. GlaxoSmithKline Corporation Information
Table 92. GlaxoSmithKline Description and Business Overview
Table 93. GlaxoSmithKline Anti-inflammatory Therapeutics Product
Table 94. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. GlaxoSmithKline Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 96. GlaxoSmithKline Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 97. GlaxoSmithKline Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 98. GlaxoSmithKline Recent Developments
Table 99. Sun Pharmaceutical Industries Ltd Corporation Information
Table 100. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 101. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
Table 102. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Sun Pharmaceutical Industries Ltd Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 104. Sun Pharmaceutical Industries Ltd Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 105. Sun Pharmaceutical Industries Ltd Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 106. Sun Pharmaceutical Industries Ltd Recent Developments
Table 107. TEVA Corporation Information
Table 108. TEVA Description and Business Overview
Table 109. TEVA Anti-inflammatory Therapeutics Product
Table 110. TEVA Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. TEVA Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 112. TEVA Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 113. TEVA Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 114. TEVA Recent Developments
Table 115. North America Anti-inflammatory Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Anti-inflammatory Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Anti-inflammatory Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Anti-inflammatory Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Anti-inflammatory Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Anti-inflammatory Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 135. Anti-inflammatory Therapeutics Key Raw Materials, Industry Status and Trend
Table 136. Anti-inflammatory Therapeutics Key Raw Materials and Upstream Suppliers
Table 137. Anti-inflammatory Therapeutics Clients Status and Trend
Table 138. Anti-inflammatory Therapeutics Typical Clients
Table 139. Anti-inflammatory Therapeutics Distributors
Table 140. Anti-inflammatory Therapeutics Market Trends
Table 141. Anti-inflammatory Therapeutics Market Drivers
Table 142. Anti-inflammatory Therapeutics Market Challenges
Table 143. Anti-inflammatory Therapeutics Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-inflammatory Therapeutics Product Picture
Figure 2. Global Anti-inflammatory Therapeutics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Anti-inflammatory Therapeutics Revenue Market Share by Type in 2024 & 2031
Figure 4. Anti-inflammatory Biologics Product Picture
Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture
Figure 6. Corticosteroids Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-inflammatory Therapeutics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Anti-inflammatory Therapeutics Revenue Market Share by Application in 2024 & 2031
Figure 10. Arthritis
Figure 11. Respiratory Diseases
Figure 12. Dermatology
Figure 13. Gastroenterology
Figure 14. Others
Figure 15. Anti-inflammatory Therapeutics Report Years Considered
Figure 16. Global Anti-inflammatory Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Anti-inflammatory Therapeutics Market Size (2020-2031) & (US$ Million)
Figure 18. Global Anti-inflammatory Therapeutics Market Size Market Share by Region: 2024 Versus 2031
Figure 19. Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2020-2031)
Figure 20. Global Anti-inflammatory Therapeutics Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Global Anti-inflammatory Therapeutics Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Anti-inflammatory Biologics of Anti-inflammatory Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 23. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) of Anti-inflammatory Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 24. Corticosteroids of Anti-inflammatory Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 25. Others of Anti-inflammatory Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 26. Anti-inflammatory Therapeutics Revenue Share by Company (2024)
Figure 27. Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Anti-inflammatory Biologics Revenue Proportion by Company in 2024
Figure 29. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Revenue Proportion by Company in 2024
Figure 30. Corticosteroids Revenue Proportion by Company in 2024
Figure 31. Others Revenue Proportion by Company in 2024
Figure 32. North America Anti-inflammatory Therapeutics Revenue 2020-2031 (US$ Million)
Figure 33. North America Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 34. North America Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Anti-inflammatory Therapeutics Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 39. Europe Anti-inflammatory Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Anti-inflammatory Therapeutics Revenue Market Share by Country (2020-2031)
Figure 41. Europe Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 42. Europe Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 43. Latin America Anti-inflammatory Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Anti-inflammatory Therapeutics Revenue Market Share by Country (2020-2031)
Figure 45. Latin America Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 46. Latin America Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Anti-inflammatory Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 51. Anti-inflammatory Therapeutics Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Anti-inflammatory Therapeutics Raw Materials by Region in 2024
Figure 53. Anti-inflammatory Therapeutics Distribution Channels
Figure 54. Global Anti-inflammatory Therapeutics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Anti-inflammatory Therapeutics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Anti-inflammatory Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Anti-inflammatory Therapeutics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Anti-inflammatory Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Anti-inflammatory Therapeutics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Anti-inflammatory Therapeutics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Anti-inflammatory Therapeutics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Anti-inflammatory Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Anti-inflammatory Therapeutics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Anti-inflammatory Therapeutics Players by Revenue (US$ Million) in 2024
Table 13. Global Anti-inflammatory Therapeutics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2024)
Table 15. Global Anti-inflammatory Therapeutics Companies Headquarters
Table 16. Date of International Companies Enter into Anti-inflammatory Therapeutics Market
Table 17. Global Anti-inflammatory Therapeutics Companies Product & Service
Table 18. Global Anti-inflammatory Therapeutics Mergers & Acquisitions, Expansion Plans
Table 19. AbbVie Corporation Information
Table 20. AbbVie Description and Business Overview
Table 21. AbbVie Anti-inflammatory Therapeutics Product
Table 22. AbbVie Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. AbbVie Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 24. AbbVie Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 25. AbbVie Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 26. AbbVie Recent Developments
Table 27. Johnson & Johnson Corporation Information
Table 28. Johnson & Johnson Description and Business Overview
Table 29. Johnson & Johnson Anti-inflammatory Therapeutics Product
Table 30. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Johnson & Johnson Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 32. Johnson & Johnson Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 33. Johnson & Johnson Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 34. Johnson & Johnson Recent Developments
Table 35. Amgen Inc Corporation Information
Table 36. Amgen Inc Description and Business Overview
Table 37. Amgen Inc Anti-inflammatory Therapeutics Product
Table 38. Amgen Inc Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Amgen Inc Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 40. Amgen Inc Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 41. Amgen Inc Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 42. Amgen Inc Recent Developments
Table 43. AstraZeneca PLC Corporation Information
Table 44. AstraZeneca PLC Description and Business Overview
Table 45. AstraZeneca PLC Anti-inflammatory Therapeutics Product
Table 46. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. AstraZeneca PLC Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 48. AstraZeneca PLC Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 49. AstraZeneca PLC Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 50. AstraZeneca PLC Recent Developments
Table 51. Pfizer, Inc Corporation Information
Table 52. Pfizer, Inc Description and Business Overview
Table 53. Pfizer, Inc Anti-inflammatory Therapeutics Product
Table 54. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Pfizer, Inc Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 56. Pfizer, Inc Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 57. Pfizer, Inc Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 58. Pfizer, Inc Recent Developments
Table 59. Novartis Corporation Information
Table 60. Novartis Description and Business Overview
Table 61. Novartis Anti-inflammatory Therapeutics Product
Table 62. Novartis Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Novartis Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 64. Novartis Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 65. Novartis Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 66. Novartis Recent Developments
Table 67. Roche Corporation Information
Table 68. Roche Description and Business Overview
Table 69. Roche Anti-inflammatory Therapeutics Product
Table 70. Roche Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Roche Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 72. Roche Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 73. Roche Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 74. Roche Recent Developments
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Anti-inflammatory Therapeutics Product
Table 78. Merck Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Merck Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 80. Merck Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 81. Merck Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 82. Merck Recent Developments
Table 83. Sanofi Corporation Information
Table 84. Sanofi Description and Business Overview
Table 85. Sanofi Anti-inflammatory Therapeutics Product
Table 86. Sanofi Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Sanofi Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 88. Sanofi Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 89. Sanofi Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 90. Sanofi Recent Developments
Table 91. GlaxoSmithKline Corporation Information
Table 92. GlaxoSmithKline Description and Business Overview
Table 93. GlaxoSmithKline Anti-inflammatory Therapeutics Product
Table 94. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. GlaxoSmithKline Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 96. GlaxoSmithKline Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 97. GlaxoSmithKline Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 98. GlaxoSmithKline Recent Developments
Table 99. Sun Pharmaceutical Industries Ltd Corporation Information
Table 100. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 101. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
Table 102. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Sun Pharmaceutical Industries Ltd Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 104. Sun Pharmaceutical Industries Ltd Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 105. Sun Pharmaceutical Industries Ltd Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 106. Sun Pharmaceutical Industries Ltd Recent Developments
Table 107. TEVA Corporation Information
Table 108. TEVA Description and Business Overview
Table 109. TEVA Anti-inflammatory Therapeutics Product
Table 110. TEVA Anti-inflammatory Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. TEVA Revenue Proportion of Anti-inflammatory Therapeutics by Product in 2024
Table 112. TEVA Revenue Proportion of Anti-inflammatory Therapeutics by Application in 2024
Table 113. TEVA Revenue Proportion of Anti-inflammatory Therapeutics by Geographic Area in 2024
Table 114. TEVA Recent Developments
Table 115. North America Anti-inflammatory Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Anti-inflammatory Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Anti-inflammatory Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Anti-inflammatory Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Anti-inflammatory Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Anti-inflammatory Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Anti-inflammatory Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 135. Anti-inflammatory Therapeutics Key Raw Materials, Industry Status and Trend
Table 136. Anti-inflammatory Therapeutics Key Raw Materials and Upstream Suppliers
Table 137. Anti-inflammatory Therapeutics Clients Status and Trend
Table 138. Anti-inflammatory Therapeutics Typical Clients
Table 139. Anti-inflammatory Therapeutics Distributors
Table 140. Anti-inflammatory Therapeutics Market Trends
Table 141. Anti-inflammatory Therapeutics Market Drivers
Table 142. Anti-inflammatory Therapeutics Market Challenges
Table 143. Anti-inflammatory Therapeutics Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-inflammatory Therapeutics Product Picture
Figure 2. Global Anti-inflammatory Therapeutics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Anti-inflammatory Therapeutics Revenue Market Share by Type in 2024 & 2031
Figure 4. Anti-inflammatory Biologics Product Picture
Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Product Picture
Figure 6. Corticosteroids Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-inflammatory Therapeutics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Anti-inflammatory Therapeutics Revenue Market Share by Application in 2024 & 2031
Figure 10. Arthritis
Figure 11. Respiratory Diseases
Figure 12. Dermatology
Figure 13. Gastroenterology
Figure 14. Others
Figure 15. Anti-inflammatory Therapeutics Report Years Considered
Figure 16. Global Anti-inflammatory Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Anti-inflammatory Therapeutics Market Size (2020-2031) & (US$ Million)
Figure 18. Global Anti-inflammatory Therapeutics Market Size Market Share by Region: 2024 Versus 2031
Figure 19. Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2020-2031)
Figure 20. Global Anti-inflammatory Therapeutics Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Global Anti-inflammatory Therapeutics Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Anti-inflammatory Biologics of Anti-inflammatory Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 23. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) of Anti-inflammatory Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 24. Corticosteroids of Anti-inflammatory Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 25. Others of Anti-inflammatory Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 26. Anti-inflammatory Therapeutics Revenue Share by Company (2024)
Figure 27. Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Anti-inflammatory Biologics Revenue Proportion by Company in 2024
Figure 29. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Revenue Proportion by Company in 2024
Figure 30. Corticosteroids Revenue Proportion by Company in 2024
Figure 31. Others Revenue Proportion by Company in 2024
Figure 32. North America Anti-inflammatory Therapeutics Revenue 2020-2031 (US$ Million)
Figure 33. North America Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 34. North America Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Anti-inflammatory Therapeutics Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 39. Europe Anti-inflammatory Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Anti-inflammatory Therapeutics Revenue Market Share by Country (2020-2031)
Figure 41. Europe Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 42. Europe Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 43. Latin America Anti-inflammatory Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Anti-inflammatory Therapeutics Revenue Market Share by Country (2020-2031)
Figure 45. Latin America Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 46. Latin America Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Anti-inflammatory Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Figure 51. Anti-inflammatory Therapeutics Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Anti-inflammatory Therapeutics Raw Materials by Region in 2024
Figure 53. Anti-inflammatory Therapeutics Distribution Channels
Figure 54. Global Anti-inflammatory Therapeutics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Anti-inflammatory Therapeutics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Advanced Enteric Capsules Market Research Report 2025
Jul 08, 25
Global Outdoor Structures and Chairs Market Research Report 2025
Jul 08, 25
Global Herbs Ingredients Market Research Report 2025
Jul 08, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232